postpartum hemorrhage [message #1563] |
Thu, 13 March 2014 15:35 ![Go to next message Go to next message](/theme/default/images/down.png) |
pstephenson
Messages: 1 Registered: March 2014
|
Member |
|
|
The DHS needs a question on whether the woman received oxytocin injection or misoprostol by mouth at the time of delivery.
If you need to drop a question I have my doubts about the usefulness of question 423 (did you take a drug for intestinal worms). Obviously if one is focused on anemia 423 would be important but receiving a prophylactic uterotonic to prevent postpartum hemorrhage is a major component of maternal health programs and should be collected. The other question that might be deleted would be 419 since it could be highly subject to recall bias. It would be useful to check the validity and reliability of answers to this.
|
|
|
|
Re: postpartum hemorrhage [message #1938 is a reply to message #1698] |
Thu, 10 April 2014 10:29 ![Go to previous message Go to previous message](/theme/default/images/up.png) |
amoran
Messages: 6 Registered: April 2014 Location: Washington DC
|
Member |
|
|
I also strongly agree that we need a question on prophylactic use of oxytocin to prevent PPH. However, given the results of the Mozambique validation study (PLoS One), it is not feasible to include this type of question in a household survey. I agree that we will need to work to get this information from facility-based data. However, it is important to assess the feasibility of asking about use of misoprostol tablets to prevent PPH.
|
|
|